Business ❯Pharmaceuticals ❯Mergers and Acquisitions

Bristol Myers Squibb

Karuna Therapeutics Turnaround Mirati Therapeutics

Bristol Myers Squibb Acquires Karuna Therapeutics in $14 Billion Deal